The feasibility of a medically supervised preoperative weight loss program in patients with obesity and atypical hyperplasia, or low-grade endometrial carcinoma

Gynecologic Oncology · Published 2026-08-04 · DOI 10.1016/j.ygyno.2026.07.024

Free full text

Authors (7)

Christa Aubrey, Bruno Svajger, Jesse Batara, Sarah Chapelsky, Courtney Tromburg, Logan Richard, Sophia Pin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Aubrey, C., Svajger, B., Batara, J., et al. (2026). The feasibility of a medically supervised preoperative weight loss program in patients with obesity and atypical hyperplasia, or low-grade endometrial carcinoma. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2026.07.024

Related articles

• Psychometric evaluation of the NFOSI-18 disease related symptoms – Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004 · Gynecologic Oncology · 2026 · Same journal
• Stereotactic body radiotherapy for oligorecurrent granulosa cell tumours · Gynecologic Oncology · 2026 · Same journal
• Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer · Gynecologic Oncology · 2026 · Same journal
• Failure to rescue after major gynecologic cancer surgery: A National Surgical Quality Improvement Program analysis · Gynecologic Oncology · 2026 · Same journal
• Risk of endometrial carcinoma in patients with atypical endometrial hyperplasia in a population of predominantly racial and ethnic minorities, a single institution study · Gynecologic Oncology · 2026 · Same journal
• Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancer · Gynecologic Oncology · 2026 · Same journal
• Validation of the 2025 ESGO/ESTRO/ESP postoperative risk stratification system in endometrial cancer: A same-cohort comparison with the 2020 molecular classification · Gynecologic Oncology · 2026 · Same journal
• Clitoral reconstructive surgery for patients with vulvar carcinoma · Gynecologic Oncology · 2026 · Same journal
• Folate receptor alpha, TROP2 and HER2 in high-grade serous ovarian cancer: Expression and clinicopathological correlations · Gynecologic Oncology · 2026 · Same journal
• No time to waste: Evaluation of diagnostic delays in vulvar cancer · Gynecologic Oncology · 2026 · Same journal